Use este identificador para citar ou linkar para este item:
http://www.alice.cnptia.embrapa.br/alice/handle/doc/948750Registro completo de metadados
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | GASPAR, E. B. | |
| dc.contributor.author | SANTOS, L. R. dos | |
| dc.contributor.author | ARAUJO, F. R. | |
| dc.contributor.author | GULIAS-GOMES, C. C. | |
| dc.contributor.author | LINCOPAN, N. | |
| dc.contributor.author | BRANDAO, H. de M. | |
| dc.contributor.author | ROSINHA, G. M. S. | |
| dc.date.accessioned | 2025-06-25T15:47:47Z | - |
| dc.date.available | 2025-06-25T15:47:47Z | - |
| dc.date.created | 2013-02-07 | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | In: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012. | |
| dc.identifier.uri | http://www.alice.cnptia.embrapa.br/alice/handle/doc/948750 | - |
| dc.description | This project aims the development of a new vaccine against babesiosis and anaplasmosis based on a chimeric protein and new adjuvants. A chimeric protein formed by Anaplasma marginale VirB9 and Virb10 protein and B. bigemina PO protein will be constructed by genetic engineering. | |
| dc.language.iso | eng | |
| dc.rights | openAccess | |
| dc.title | Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale associated with nanoparticles adjuvants. | |
| dc.type | Resumo em anais e proceedings | |
| dc.subject.thesagro | Anaplasmose | |
| dc.subject.thesagro | Babesiose | |
| dc.subject.thesagro | Vacina | |
| dc.format.extent2 | p. 153. | |
| riaa.ainfo.id | 948750 | |
| riaa.ainfo.lastupdate | 2025-06-25 | |
| dc.contributor.institution | EMANUELLE BALDO GASPAR, CPPSUL; LENITA RAMIRES DOS SANTOS, CNPGC; FLABIO RIBEIRO ARAUJO, CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; N. LINCOPAN, USP; HUMBERTO DE MELLO BRANDAO, CNPGL; GRACIA MARIA SOARES ROSINHA, CNPGC. | |
| Aparece nas coleções: | Resumo em anais de congresso (CNPGL)  | |
Arquivos associados a este item:
| Arquivo | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| Development-of-recombinant-vaccine.pdf | 377.57 kB | Adobe PDF |  Visualizar/Abrir |
